{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:54:26Z","timestamp":1793141666017,"version":"4.5.0"},"reference-count":48,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,12,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Improvements in hemophilia care and antiviral treatments have resulted in increases in median life expectancy for persons with congenital hemophilia A and B. Currently, 2% of hemophilia A and B patients surveyed in US comprehensive hemophilia treatment centers are 65 years of age or older and 15% are 45 years or older. Many of the complications of hemophilia, including intracranial hemorrhage, joint disease, and inhibitor development, increase with increasing age. Hepatocellular carcinoma and end-stage liver disease are increasing in the older hemophilia population due to infection with hepatitis C (HCV) and HCV\/HIV coinfection. Older hemophilia patients also now face the same medical conditions associated with aging in the general population, including cardiovascular disease and cancer. Complex hemostatic management, sometimes in conjunction with antithrombotic management, with extensive cross-specialty clinical and laboratory coordination may be required for the care of the older hemophilia patient. Because elderly hemophilia patients currently represent a small portion of the overall hemophilia population, there is little in the way of clinical data to guide recommendations. Registry databases and cooperative group studies are needed for the development of evidence-based guidelines for the older hemophilia population, which is anticipated to expand in the future.<\/jats:p>","DOI":"10.1182\/asheducation-2010.1.191","type":"journal-article","created":{"date-parts":[[2011,1,16]],"date-time":"2011-01-16T19:08:48Z","timestamp":1295204928000},"page":"191-196","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":54,"title":["The Aging Patient with Hemophilia: Complications, Comorbidities, and Management Issues"],"prefix":"10.1182","volume":"2010","author":[{"given":"Claire","family":"Philipp","sequence":"first","affiliation":[{"name":"University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111715543189800_B1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2516.2008.01708.x","article-title":"Back to the future: a recent history of hemophilia treatment","volume":"14","author":"Mannucci","year":"2008","journal-title":"Hemophilia"},{"issue":"2","key":"2019111715543189800_B2","first-page":"437","article-title":"Hemophilia Surveillance System Project Investigators. Mortality among males with hemophilia: relations with source of medical care","volume":"96","author":"Soucie","year":"2000","journal-title":"Blood"},{"key":"2019111715543189800_B3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1046\/j.1365-2516.2001.00484.x","article-title":"the Hemophilia Surveillance System Project Investigators. Home-based factor infusion therapy and hospitalization for bleeding complications among males with haemophilia","volume":"7","author":"Soucie","year":"2001","journal-title":"Haemophilia"},{"key":"2019111715543189800_B4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa067659","article-title":"Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia","volume":"357","author":"Manco-Johnson","year":"2007","journal-title":"N Engl J Med"},{"key":"2019111715543189800_B5","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1538-7836.2006.01808.x","article-title":"Mortality and causes of death in patients with hemophilia, 1992\u20132001:a prospective cohort study","volume":"4","author":"Plug","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2019111715543189800_B6","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood-2006-10-050435","article-title":"Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV","volume":"110","author":"Darby","year":"2007","journal-title":"Blood"},{"key":"2019111715543189800_B7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ajh.1050","article-title":"Effects of HIV infection on age and cause of death for persons with Hemophilia A in the United States","volume":"66","author":"Chorba","year":"2001","journal-title":"Am J Hematol"},{"key":"2019111715543189800_B8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2516.2008.01946.x","article-title":"Haemophilia care then, now and in the future","volume":"15","author":"Oldenberg","year":"2009","journal-title":"Haemophilia"},{"key":"2019111715543189800_B9","first-page":"365","article-title":"Pneumocystis carinii pneumonia among persons with hemophilia A","volume":"31","author":"Centers for Disease Control and Prevention (CDC)","year":"1982","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2019111715543189800_B10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1537-2995.2001.41030338.x","article-title":"Risk factors for infection with HBV and HCV in a large cohort of hemophiliac males","volume":"41","author":"Soucie","year":"2001","journal-title":"Transfusion"},{"key":"2019111715543189800_B11","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2516.2009.02188.x","article-title":"Mortality and causes of death in Italian persons with haemophilia","volume":"16","author":"Tagliaferri","year":"2010","journal-title":"Haemophilia"},{"key":"2019111715543189800_B12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1538-7836.2009.03318.x","article-title":"Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy","volume":"7","author":"Siboni","year":"2009","journal-title":"J Thromb Haemost"},{"key":"2019111715543189800_B13","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2516.2008.01702.x","article-title":"Coping with the HIV epidemic 1982\u20132007:25-year outcomes of the Hershey Hemophilia Cohort","volume":"14","author":"Eyster","year":"2008","journal-title":"Haemophilia"},{"issue":"2","key":"2019111715543189800_B14","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1182\/blood-2005-11-4407","article-title":"Mortality rates and causes of death among all HIV positive individuals with hemophilia in Canada over 21 years of follow-up","volume":"108","author":"Arnold","year":"2006","journal-title":"Blood"},{"key":"2019111715543189800_B15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jinf.2004.04.003","article-title":"Clinical outcomes of HIV-HCV coinfection in a large cohort of hemophiliac patients","volume":"50","author":"Lichterfeld","year":"2005","journal-title":"J Infect"},{"key":"2019111715543189800_B16","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00002030-200402200-00020","article-title":"The impact of HIV on mortality rates in the complete UK haemophilia population","volume":"18","author":"Darby","year":"2004","journal-title":"AIDS"},{"key":"2019111715543189800_B17","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1182\/blood-2006-08-038349","article-title":"Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study","volume":"109","author":"Posthouwer","year":"2007","journal-title":"Blood"},{"key":"2019111715543189800_B18","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2516.2008.01935.x","article-title":"Highly active antiretroviral therapy improves ESLD-free survival in HIV-HCV co-infection","volume":"15","author":"Ragni","year":"2009","journal-title":"Haemophilia"},{"key":"2019111715543189800_B19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2516.2010.02292.x","article-title":"Viral pathogens","volume":"16","author":"Ragni","year":"2010","journal-title":"Haemophilia"},{"key":"2019111715543189800_B20","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1111\/j.1538-7836.2007.02619.x","article-title":"Antiviral therapy for chronic hepatitis in patients with inherited bleeding disorders: an international, multicenter cohort study","volume":"5","author":"Posthouwer","year":"2007","journal-title":"J Thromb Haemostasis"},{"key":"2019111715543189800_B21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ajh.20263","article-title":"A Canadian multicenter retrospective study evaluating transjugular liver biopsy in patients with congenital bleeding disorders and hepatitis C: is it safe and useful?","volume":"78","author":"Shin","year":"2005","journal-title":"Am J Hematology"},{"key":"2019111715543189800_B22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1538-7836.2006.02272.x","article-title":"Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography","volume":"5","author":"Posthouwer","year":"2007","journal-title":"J Thromb Haemost"},{"key":"2019111715543189800_B23","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1365-2516.2009.02029.x","article-title":"Survival in a cohort of patients with haemophilia at the haemophilia care center in Vienna, Austria, from 1993 to 2006","volume":"15","author":"Reitter","year":"2009","journal-title":"Haemophilia"},{"key":"2019111715543189800_B24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ajh.1146","article-title":"Changes in the occurrence of and risk factors for hemophilia-associated intracranial hemorrhage","volume":"68","author":"Nuss","year":"2001","journal-title":"Am J Hematol"},{"key":"2019111715543189800_B25","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1046\/j.1538-7836.2004.00710.x","article-title":"The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977\u201399","volume":"2","author":"Darby","year":"2004","journal-title":"J Thromb Haemost"},{"key":"2019111715543189800_B26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2516.2009.02159.x","article-title":"Controversies regarding the prophylactic management of adults with severe hemophilia A","volume":"15","author":"Valentino","year":"2009","journal-title":"Haemophilia"},{"key":"2019111715543189800_B27","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1365-2141.2007.06949.x","article-title":"Intracranial haemorrhage in haemophilia A and B","volume":"140","author":"Ljung","year":"2007","journal-title":"Br J Haematology"},{"key":"2019111715543189800_B28","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-2516.2009.01987.x","article-title":"Co-morbidity in the ageing haemophilia patient: the down side of increased life expectancy","volume":"15","author":"Mauser-Bunschoten","year":"2009","journal-title":"Haemophilia"},{"key":"2019111715543189800_B29","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1365-2516.2009.02066.x","article-title":"Emerging clinical concerns in the ageing haemophilia patient","volume":"15","author":"Konkle","year":"2009","journal-title":"Haemophilia"},{"key":"2019111715543189800_B30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2516.2007.01453.x","article-title":"Upper gastrointestinal bleeding in haemophiliacs: incidence and relation to use of non-steroidal anti-inflammatory drugs","volume":"13","author":"Eyster","year":"2007","journal-title":"Haemophilia"},{"key":"2019111715543189800_B31","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2516.2008.01653.x","article-title":"Paracetamol\/acetaminophen usage in haemophilia: more caution needed?","volume":"14","author":"Van Veen","year":"2008","journal-title":"Haemophilia"},{"key":"2019111715543189800_B32","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2516.2007.01478.x","article-title":"Should prophylaxis be used in adolescent and adult patients with severe haemophilia?","volume":"13","author":"Richards","year":"2007","journal-title":"Haemophilia"},{"key":"2019111715543189800_B33","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1182\/blood-2009-07-215665","article-title":"How I treat age-related morbidities in elderly persons with hemophilia","volume":"114","author":"Mannucci","year":"2009","journal-title":"Blood"},{"key":"2019111715543189800_B34","first-page":"15","article-title":"Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations","author":"Hermans","year":"2009","journal-title":"Haemophilia"},{"key":"2019111715543189800_B35","first-page":"928","article-title":"Intensive peri-operative use of factor VIII and the Arg593 cys mutation are risk factors for inhibitor development","volume":"7","author":"Eckhart","year":"2009","journal-title":"J Thromb Haemost"},{"key":"2019111715543189800_B36","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1365-2516.2008.01839.x","article-title":"Immune tolerance with rituximab in congenital haemophilia with inhibitors: a systematic literature review based on individual patients' analysis","volume":"14","author":"Franchini","year":"2008","journal-title":"Haemophilia"},{"key":"2019111715543189800_B37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ajh.20339","article-title":"Prevalence and risk factors for heart disease among males with hemophilia","volume":"79","author":"Kulkarni","year":"2005","journal-title":"Am J Hematol"},{"key":"2019111715543189800_B38","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1538-7836.2008.03201.x","article-title":"Cardiovascular disease in patients with hemophilia","volume":"7","author":"Tuinenburg","year":"2008","journal-title":"J Thromb Haemost"},{"key":"2019111715543189800_B39","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1538-7836.2009.03669.x","article-title":"Coronary atherosclerosis and cardiovascular mortality in hemophilia","volume":"8","author":"Foley","year":"2010","journal-title":"J Thromb Haemost"},{"key":"2019111715543189800_B40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2516.2006.01254.x","article-title":"Haemophilia and ageing","volume":"12","author":"Street","year":"2006","journal-title":"Haemophilia"},{"key":"2019111715543189800_B41","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/CIRCHEARTFAILURE.109.854943","article-title":"Impact of HIV infection on diastolic function and left ventricular mass","volume":"3","author":"Hsue","year":"2010","journal-title":"Circ Heart Fail"},{"key":"2019111715543189800_B42","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIR.0b013e3181d2c863","article-title":"Assessing risk for cardiovascular disease in patients with human immunodeficiency virus","volume":"121","author":"Sax","year":"2010","journal-title":"Circulation"},{"key":"2019111715543189800_B43","first-page":"15","article-title":"Cardiac surgery in patients with haemophilia","author":"Tang","year":"2009","journal-title":"Haemophilia"},{"key":"2019111715543189800_B44","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/j.1365-2516.2009.02020.x","article-title":"Treatment of ischaemic heart disease in haemophilia patients: an institutional guideline","volume":"15","author":"Schutgens","year":"2009","journal-title":"Haemophilia"},{"key":"2019111715543189800_B45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2516.2010.02287.x","article-title":"The challenge of an ageing hemophilia population","volume":"16","author":"Dolan","year":"2010","journal-title":"Haemophilia"},{"key":"2019111715543189800_B46","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ctrv.2009.01.001","article-title":"Hemophilia and cancer: a new challenge for hemophilia centers","volume":"35","author":"Franchini","year":"2009","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"2019111715543189800_B47","first-page":"1173","article-title":"A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C","volume":"91","author":"Tradati","year":"1998","journal-title":"Blood"},{"issue":"1","key":"2019111715543189800_B48","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00535-009-0131-x","article-title":"Regular surveillance by imaging for early detection and better prognosis of hepatocellular carcinoma in patients infected with hepatitis C virus","volume":"45","author":"Noda","year":"2010","journal-title":"J Gastroenterology"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2010\/1\/191\/1492485\/bep00110000191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2010\/1\/191\/1492485\/bep00110000191.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T05:29:56Z","timestamp":1712122196000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2010\/1\/191\/96370\/The-Aging-Patient-with-Hemophilia-Complications"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,4]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12,4]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2010.1.191","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,4]]}}}